Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 2/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 6/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | DHFR | P00374 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2786708 | 0.93 | CYP2C19 (0.67) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL11679351 | 0.91 | HSPA5 (0.59) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL30903568 | 0.91 | HSPA5 (0.66) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL29500375 | 0.91 | HSPA5 (0.66) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL39554 | 0.91 | HSPA5 (0.66) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL3685892 | 0.89 | HSPA5 (0.63) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL8055757 | 0.86 | CYP2C19 (0.80) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL7110304 | 0.83 | CYP2C9 (0.52) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL14431780 | 0.83 | HSPA5 (0.61) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL31281158 | 0.83 | HSPA5 (0.83) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203817-A1 | STABILIZED SPANDEX COMPOSITIONS | CYTEC TECHNOLOGY CORP. | 2009-08-13 | — | — | US | disclosed |
| WO-2007120749-A1 | STABILIZED SPANDEX COMPOSITIONS | CYTEC TECHNOLOGY CORP. (US) | 2007-10-25 | — | — | WO | disclosed |
| US-20070032581-A1 | Additive mixtures | CIBA CORPORATION | 2007-02-08 | — | — | US | disclosed |
| US-20060293416-A1 | Polyester masterbatch composition | POLYMERS AUSTRALIA PTY. LIMITED (AU) | 2006-12-28 | — | — | US | disclosed |
| US-4898901-A | Long chain N-alkyl-alpha-alkyl nitrones and polyolefin compositions stabilized therewith | CIBA-GEIGY CORPORATION (US) | 1990-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203817-A1 | STABILIZED SPANDEX COMPOSITIONS | SMCHD1, SMC1A, SI | HSPA5 163/4885CYP2C19 561/4885CYP2C9 985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.